MENU

NNVC NanoViricides Forecast, Technical & Fundamental Analysis

a developer of anti-viral therapeutics

Industry Biotechnology
NNVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
NNVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NNVC is expected to report earnings to fall 48.48% to -17 cents per share on August 30

NanoViricides NNVC Stock Earnings Reports
Q2'23
Est.
$-0.17
Q1'24
Missed
by $0.18
Q4'23
Missed
by $0.01
Q3'23
Est.
$-0.17
Q1'23
Est.
$-0.15
The last earnings report on May 14 showed earnings per share of -33 cents, missing the estimate of -15 cents. With 102.91K shares outstanding, the current market capitalization sits at 18.69M.
A.I. Advisor
published General Information

General Information

a developer of anti-viral therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Controls Drive
Phone
+1 203 937-6137
Employees
7
Web
http://www.nanoviricides.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

NNVC and Stocks

Correlation & Price change

A.I.dvisor tells us that NNVC and ZNTL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNVC and ZNTL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
-0.74%
ZNTL - NNVC
25%
Poorly correlated
+0.77%
POLBF - NNVC
24%
Poorly correlated
N/A
SYRE - NNVC
23%
Poorly correlated
-5.18%
PRME - NNVC
23%
Poorly correlated
-9.22%
DRMA - NNVC
23%
Poorly correlated
-3.34%
More

Groups containing NNVC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
-0.74%
drugs
theme (254 stocks)
13%
Poorly correlated
-4.03%
biotechnology
theme (238 stocks)
6%
Poorly correlated
-4.32%
therapy
theme (23 stocks)
3%
Poorly correlated
-7.42%